This Week in Virology

TWiV is a weekly netcast about viruses - the kind that make you sick. Brought to you by four university professors and a science writer.

http://www.microbe.tv/twiv

subscribe
share






episode 932: Clinical update with Dr. Daniel Griffin


In his weekly clinical update Dr. Griffin discusses vaccine effectiveness against influenza illness in children, clinical manifestations of infection with poliovirus, spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice, concordance of SARS-CoV-2 results in self-collected nasal swabs vs swabs collected by health care workers in children and adolescents, probable animal-to-human transmission of SARS-CoV-2 causing a pet shop-related outbreak, laboratory-confirmed COVID-19–associated hospitalizations among adults during BA.2 variant, SARS-CoV-2 specific T-cells and antibodies, Nirmatrelvir use and outcomes during the Omicron surge, real-world effectiveness of early Molnupiravir or Nirmatrelvir–ritonavir in hospitalized patients, and distinguishing features of long COVID.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode
  • Vaccine effectiveness against Influenza illness in children (CID)
  • Clinical manifestations of infection with Polio (JAMA)
  • Characteristics of deaths among fully vaccinated persons with Coronavirus (CID)
  • Spike protein attenuation of Omicron Variant in lab mice (Cell Reports)
  • Concordance of SARS-CoV-2 results in nasal swabs self-collected vs healthcare collected (JAMA)
  • Probable animal-to-human transmission of Sars-Cov-2 (CID)
  • PAXLOVID patient eligibility screening checklist (FDA)
  • Remdesivir fact sheet for providers (Veklury) 
  • Bebtelovimab fact sheet for providers (FDA)
  • COVID-19–associated hospitalizations among adults during BA.2 variant (CDC)
  • Sars-Cov-2 specific T-cells and antibodies (CID)
  • Nirmatrelvir use and outcomes during the Omicron surge (NEJM)
  • Effectiveness of early Molnupiravir or Nirmatrelvir–Ritonavir in hospitalized patients (The Lancet)
  • Distinguishing features of long COVID (medRxiv)
  • Unexplained post-acute infection syndromes (Nature Med)
  • Contribute to Floating Doctors fundraiser at PWB
  • Dr. Griffin’s treatment guide (pdf)
  • Letters read on TWiV 932
  • Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv


fyyd: Podcast Search Engine
share








 September 3, 2022  49m